Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PTGX - Protagonist Therapeutics stock rises on Takeda license deal

PTGX - Protagonist Therapeutics stock rises on Takeda license deal

Protagonist Therapeutics Inc.

2024-02-01 09:12:12 ET

Protagonist Therapeutics ( NASDAQ: PTGX ) shares gained around 6% premarket on Thursday after the biopharma firm entered into a global license and collaboration deal with Takeda ( NYSE: TAK ) for the development and commercialization of its investigational drug, rusfertide....

For further details see:

Protagonist Therapeutics stock rises on Takeda license deal
Stock Information
Company Name: Protagonist Therapeutics Inc.
Stock Symbol: PTGX
Market: NASDAQ
Website: protagonist-inc.com
Menu
PTGX PTGX Quote PTGX Short PTGX News PTGX Articles PTGX Message Board
Get PTGX Alerts

News, Short Squeeze, Breakout and More Instantly...